期刊文献+

457例心脏手术患者临床用血趋势分析 被引量:3

Trend analysis of clinical use of blood in 457 patients with cardiac surgery
原文传递
导出
摘要 目的:通过对我院心脏手术患者临床用血情况的统计与分析,为输血科合理储血、血站计划采血及临床科室用血提供有价值的参考信息。方法:对2014-01-2016-03明确临床诊断的457例心脏手术患者的临床输血资料,按年龄段、性别、病种、血型对期间心脏手术的例数进行回顾性分析,并按性别、病种、血型对心脏手术各成分血悬浮红细胞(S-RBC)、冰冻血浆(FP)和冷沉淀凝血因子(CRYO AHF)的用量进行统计分析。结果:457例心脏手术中男269例,女188例,性别差异有统计学意义;A型150例,B型120例,O型134例,AB型53例,由于AB型人群较少,所以各血型间心脏手术例数并无显著差异。457例心脏手术患者悬浮红细胞用量共计1 529U,冰冻血浆302 400ml,冷沉淀凝血因子670U。其中0~6岁年龄段房间隔缺损和室间隔缺损的手术最多,平均每例用血量为红细胞悬液2.4U,冰冻血浆300ml。50岁以上年龄段以冠状动脉粥样硬化性心脏病为多,以男性居多,平均每例用血量为红细胞悬液3.8U,冰冻血浆820ml,冷沉淀凝血因子1.9U,其次为瓣膜疾病数量居多。其他类型心脏病如法洛四联症、心脏肿瘤、心肌病等类型心脏病手术较少。结论:通过我院心脏手术患者输血情况的分析,总结出各类型心脏病的备血经验,有助于输血科制定储血计划,同时将结果反馈给血站,使血站采血有据可依,力求做到合理备血,安全用血,节约用血。 Objective:To count and analyze the clinical data of the patients with cardiac surgery in our hospital, and obtain valuable reference information for the reasonable blood storage of Department of blood transfusion, the planned blood collection of blood bank, and the clinical work in the future. Method: We collected the clinical data of 457 cardiac surgery patients from January 2014 to March 2016, The number of cardiac surgery cases was analyzed retrospectively according to age, gender, disease and blood type. Statistical analysis was carried out on the blood use amount of suspension red blood cells, frozen plasma and cryoprecipitated antihemophilic factor in the cardiac surgery according to age, gender, disease and blood type. Result: In 457 cases of cardiac surgery, 269 cases were male, 188 cases were female, and the gender difference was significant. 150 cases were A blood type, 120 cases were B blood type, 134 cases were O blood type, and 53 cases were AB blood type. Because the AB blood type population was less, there was no significant difference in the number of cardiac surgery among different blood groups. The total blood use amount of suspended red blood cells was 1 529 U, frozen plasma was 302 400 ml,and cryoprecipitated antihemophilic factor was 670 U in the 457 cases of cardiac surgery patients. The cardiac surgery patients with atrial septal defect and ventricular septal defect were the most among the 0 to 6 age group, and the average use of suspension red blood cell was 2.4 U, frozen plasma was 300 ml. The cardiac surgery patients with coronary atherosclerotic heart disease were the most among the more than 50 age group, and the majority was male, the average use of suspension red blood cell was 3.8 U, frozen plasma was 820 ml, cryoprecipitated antihemophilic factor was 1.9 U. Other types of cardiac surgery were less, such as tetralogy of Fallot, car- diac tumors and cardiomyopathy and other heart diseases. Conclusion:Through the analysis of blood transfusion of patients with cardiac surgery in our hospital, we can summarize the blood preparation experience of various types of heart disease in order to make blood storage plan for blood transfusion department, and feedback the result to the blood bank in order to make their blood sampling evidence-based. We strive to achieve reasonable preparation of blood, safe use of blood and saving blood.
出处 《临床血液学杂志(输血与检验)》 CAS 2017年第3期424-427,共4页 Journal of Clinical Hematology(Blood Transfusion & Laboratory Medicine)
关键词 心脏手术 输血 血型 性别 年龄 cardiac surgery blood transfusiomblood type gender age
  • 相关文献

参考文献8

二级参考文献78

  • 1Aikaterini Mastoraki,Emmanouil Karatzis,Sotiria Mastoraki,Ioannis Kriaras,Petros Sfirakis,Stefanos Geroulanos.Postoperative jaundice after cardiac surgery[J].Hepatobiliary & Pancreatic Diseases International,2007,6(4):383-387. 被引量:7
  • 2曾建生.心脏手术后出现高胆红素血症的临床探讨[J].检验医学,2004,19(4):371-372. 被引量:1
  • 3黎玉辉,郭新峰,王心田,马武华,庄新茂,温科辉.急性等容血液稀释血液保护的Meta分析[J].中华麻醉学杂志,2006,26(8):703-706. 被引量:14
  • 4Yong An Ying-Bin Xiao Qian-Jin Zhong.Hyperbilirubinemia after extracorporeal circulation surgery:A recent and prospective study[J].World Journal of Gastroenterology,2006,12(41):6722-6726. 被引量:20
  • 5[1]Unsworth-White MJ,Herriot A,Valencia O,et al.Resternotomy for bleeding after cardiac operation:a marker for increased morbidity and mortality.Ann Thorac Surg,1995,59(3):664
  • 6[2]Jeffrey RR,Desmond MJ.Blood and blood component use in cardiac surgery or why do cardiac surgical patients bleed? In: Duguid J,Goodnough LT,Desomond NJ(ed):Transfusion Medicine in practice.London: Martin Dunitz Ltd,2002,103~113
  • 7[3]Rich JB.The efficacy and safety of aprotinin use in cardiac surgery.Ann Thorac Surg,1998,66(5 suppl):6
  • 8[4]Alderman EL,Levy JH,Rich JB,et al.Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial.J Thorac Cardiovasc Surg,1998,116(5):716
  • 9[5]Laupacis A,Fergusson D.Drugs to minimize perioperative blood loss in cardiac surgery:meta-analyses using perioperative blood transfusion as the outcome.The International Study of Peri-operative Transfusion(ISPOT) Investigators.Anesthes Analges,1997,85(6):1258
  • 10[6]Sowade D,Warnke H,Scigallap,et al.Avoidance of allergenic blood transfusion by treatment with epoetin beta (recombinant human erythropoietin) in patients undergoing open-heart surgery.Blood,1997,89(2):411

共引文献76

同被引文献30

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部